Workflow
Arbutus Biopharma(ABUS) - 2024 Q1 - Earnings Call Transcript

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q1 2024 Earnings Conference Call May 2, 2024 8:45 AM ET Company Participants Lisa Caperelli - Vice President, Investor Relations Mike McElhaugh - Interim President and Chief Executive Officer and Director Mike Sofia - Chief Medical Officer Karen Sims - Chief Medical Officer David Hastings - Chief Financial Officer Conference Call Participants Dennis Ding - Jefferies Thomas Yip - H.C. Wainwright Roy Buchanan - Citizens JMP Keay Nakae - Chardan Operator Good day, an ...